Now showing items 1-2 of 2
Plasma sarcosine does not distinguish early and advanced stages of prostate cancer
(Health and Medical Publishing Group (HMPG), 2012-08)
Introduction. Diagnosis of prostate cancer by prostate specific antigen (PSA) is error-prone and cannot distinguish benign prostatic hyperplasia (BPH) from malignant disease, nor identify aggressive and indolent types. ...
A phase I trial of hypoxoside as an oral prodrug for cancer therapy : absence of toxicity
(Health & Medical Publishing Group, 1995)
Objective. To assess the toxicity of hypoxoside taken orally by 24 patients with lung cancer. Design. Open study with patients taking 1 200 - 3 200 mg standardised Hypoxis plant extract (200 mg capsules) per day divided ...